SGI
TECH icon

Summit Global Investments’s Bio-Techne TECH Stock Holding History

Summit Global Investments’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-9,596
Closed -$476K – 310
2019
Q1 		$476K Buy
9,596
+400
+4% +$18K 0.06% 258
2018
Q4 		$333K Sell
9,196
-183,300
-95% -$7.66M 0.05% 238
2018
Q3 		$9.82M Sell
192,496
-152
-0.1% -$6.73K 1.32% 21
2018
Q2 		$7.13M Buy
+192,648
New +$7.36M 1.07% 30

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Summit Global Investments's TECH Position: Q2 2019 in Review

Summit Global Investments sold out of Bio-Techne (TECH) in Q2 2019, closing a stake of 9,596 shares — an estimated $476K sold.

Summit Global Investments first reported a position in TECH in Q2 2018 and held it in 4 quarters. The position peaked at $9.82M in Q3 2018. 369 funds tracked by Wall St. Rank hold TECH as of Q2 2019.

  • Summit Global Investments reported no remaining Bio-Techne position as of Q2 2019 after selling out during the quarter.
  • Summit Global Investments sold 9,596 Bio-Techne shares in Q2 2019, an estimated $476K.
  • Summit Global Investments first reported a position in Bio-Techne in Q2 2018 and held it in 4 quarters.
  • Summit Global Investments's Bio-Techne position peaked at $9.82M in Q3 2018.
  • 369 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2019.

Based on Summit Global Investments's 13F filing for Q2 2019, filed 16 Aug 2019.